For example, etomoxir, an irreversible inhibitor of CPT1A [46], has been demonstrated to have pharmacological effects with the capability to treat conditions such as congestive heart failure, although its clinical effectivity remains to be studied [47]. This evidence concerns the gene CPT1A and congestive heart failure.